These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 67714)

  • 41. COMBINED ACTIVE-PASSIVE IMMUNIZATION AGAINST TETANUS WITH HUMAN IMMUNE GLOBULIN.
    RUBBON SD; SURI JC
    Med J Aust; 1965 Jul; 2(3):109-13. PubMed ID: 14335896
    [No Abstract]   [Full Text] [Related]  

  • 42. The structure and function of immunoglobulin domains. II. The importance of interchain disulfide bonds and the possible role of molecular flexibility in the interaction between immunoglobulin G and complement.
    Isenman DE; Dorrington KJ; Painter RH
    J Immunol; 1975 Jun; 114(6):1726-9. PubMed ID: 1127227
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Binding and aggregation of human gamma-globulin by cis-diamminedichloroplatinum(II) through disulfide bond.
    Chen D; Ohta N; Ukai M; Masuda M; Yotsuyanagi T
    Biol Pharm Bull; 1994 Dec; 17(12):1561-6. PubMed ID: 7537573
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical use of intravenous gamma-globulin.
    Barandun S; Morell A; Skvaril F
    Bibl Haematol; 1980; (46):170-4. PubMed ID: 6155121
    [No Abstract]   [Full Text] [Related]  

  • 45. Double-blind trial of equine antitoxin and human immune globulin in tetanus neonatorum.
    McCracken GH; Dowell DL; Marshall FN
    Lancet; 1971 Jun; 1(7710):1146-9. PubMed ID: 4102858
    [No Abstract]   [Full Text] [Related]  

  • 46. INHIBITION OF COMPLEMENT FIXATION BY HUMAN SERUM. II. THE ACTIVITY OF A GAMMA-LM GLOBULIN AND RHEUMATOID FACTOR IN COMPLEMENT FIXATION REACTIONS.
    HEIMER R; LEVIN FM; KAHN MF
    J Immunol; 1963 Dec; 91():866-72. PubMed ID: 14106313
    [No Abstract]   [Full Text] [Related]  

  • 47. Gamma-globulin and complement in the pyelonephritic kidney.
    Marosvári I; Beregi E; Szepesházi K; Román H
    Int Urol Nephrol; 1971; 3(4):429-35. PubMed ID: 4117259
    [No Abstract]   [Full Text] [Related]  

  • 48. Haemolysis induced by intravenously-administered immunoglobulin.
    Nicholls MD; Cummins JC; Davies VJ; Greenwood JK
    Med J Aust; 1989 Apr; 150(7):404-6. PubMed ID: 2469947
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The antitoxic activity and gamma globulin distribution in fractionated diphtheria and tetanus antitoxin of equine origin.
    LEVINE L
    Br J Exp Pathol; 1952 Apr; 33(2):190-5. PubMed ID: 14935082
    [No Abstract]   [Full Text] [Related]  

  • 50. Phagocytosis in subacute bacterial endocarditis. Localization of the primary opsonic site to Fc fragment.
    Quie PG; Messner RP; Williams RC
    J Exp Med; 1968 Oct; 128(4):553-70. PubMed ID: 4175321
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Undegraded -globulin for intravenous therapy. A new preparation of immune serum globulin for intravenous administration.
    Stephan W; Hainski M; Payne JH; Ordonez GA; Shanbrom E
    Vox Sang; 1971 May; 20(5):469-78. PubMed ID: 4106555
    [No Abstract]   [Full Text] [Related]  

  • 52. CURRENT STATUS OF TETANUS CONTROL. IMPORTANCE OF HUMAN TETANUS-IMMUNE GLOBULIN.
    SKUDDER PA; MCCARROLL JR
    JAMA; 1964 May; 188():625-7. PubMed ID: 14121281
    [No Abstract]   [Full Text] [Related]  

  • 53. [Human plasma gamma globulin injectable by intravenous route].
    Steinbuch M; Blatrix C; Dormont J; Soulier JP
    Presse Med (1893); 1969 Apr; 77(17):635-7. PubMed ID: 4182082
    [No Abstract]   [Full Text] [Related]  

  • 54. [Successful treatment of infantile chronic autoimmune hemolytic anemia with high-dose intravenous gamma globulin].
    Hasegawa K; Todo S; Imashuku S
    Rinsho Ketsueki; 1986 Aug; 27(8):1421-6. PubMed ID: 2432290
    [No Abstract]   [Full Text] [Related]  

  • 55. Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism.
    Theofilopoulos AN; Dixon FJ; Bokisch VA
    J Exp Med; 1974 Oct; 140(4):877-94. PubMed ID: 4139225
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Anti-D gamma globulin given intravenously for the prevention of anti-Rh immunization].
    Jouvenceaux A; Adenot N; Berthoux F; Revol L
    Prog Immunobiol Stand; 1970; 4():291-5. PubMed ID: 4098267
    [No Abstract]   [Full Text] [Related]  

  • 57. Studies on human IgD. II. The lack of skin sensitizing and complement fixing activities of immunoglobulin D.
    Henney CS; Welscher HD; Terry WD; Rowe DS
    Immunochemistry; 1969 May; 6(3):445-9. PubMed ID: 4182363
    [No Abstract]   [Full Text] [Related]  

  • 58. One-day intravenous therapy with high-dose gamma-globulin for idiopathic thrombocytopenic purpura.
    Sasaki A; Furukawa Y; Inoue T; Yamane T; Sannomiya Y; Im T; Tatsumi N
    Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):147-9. PubMed ID: 2472726
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Problems of intravenous gammaglobulin therapy (author's transl)].
    Ring J; Duswald KH
    Klin Wochenschr; 1980 Aug; 58(16):797-809. PubMed ID: 6161272
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CURRENT STATUS OF TETANUS CONTROL. IMPORTANCE OF HUMAN TETANUS-IMMUNE GLOBULIN.
    SKUDDER PA; MCCARROLL JR
    Indian Med J; 1964 Aug; 58():165-7. PubMed ID: 14194945
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.